Literature DB >> 16734802

Which patients to include in the analysis?

Regina Kunz, Gordon Guyatt.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16734802     DOI： 10.1111/j.1537-2995.2006.00854.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  3 in total

1.  Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis.

Authors:  Nasim A Khan; Juan I Lombeida; Manisha Singh; Horace J Spencer; Karina D Torralba
Journal:  Arthritis Rheum       Date:  2012-07

Review 2.  Reducing noninfectious risks of blood transfusion.

Authors:  Brian M Gilliss; Mark R Looney; Michael A Gropper
Journal:  Anesthesiology       Date:  2011-09       Impact factor: 7.892

Review 3.  Missing data in randomised controlled trials of rheumatoid arthritis drug therapy are substantial and handled inappropriately.

Authors:  Nasim A Khan; Karina D Torralba; Fawad Aslam
Journal:  RMD Open       Date:  2021-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.